GSK PLC/ GB00BN7SWP63 /
2024-08-05 9:54:14 AM | Chg. -4.00 | Volume | Bid9:55:01 AM | Ask9:55:01 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,555.50GBX | -0.26% | 164,205 Turnover(GBP): 2.57 mill. |
1,556.00Bid Size: 109 | 1,557.00Ask Size: 431 | 62.2 bill.GBP | - | - |
GlobeNewswire
07-01
Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Offi...
GlobeNewswire
06-20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
06-17
iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Pre...
GlobeNewswire
06-14
LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial
GlobeNewswire
06-14
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon...
GlobeNewswire
06-13
Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...
GlobeNewswire
06-11
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries
GlobeNewswire
06-04
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
GlobeNewswire
06-03
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
05-30
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth